About
Management
Board of Directors
Scientific Advisory Board
Pipeline
Envafolimab (KN035)
DE-122
TRC102
TRC253
TJ004309
TRC205
Clinical Trials
Partners
News
Press Releases
Publications
Investors
Press Releases
Events & Presentations
Corporate Governance
Management
Board of Directors
Committee Composition
Financials & Filings
SEC Filings
Annual Reports & Proxies
Quarterly Results
Stock Information
Historic Stock Lookup
Investment Calculator
Investor FAQ
Contact
Contact
Careers
OUR GOAL IS TO BE A LEADER IN THE DEVELOPMENT OF TARGETED THERAPIES FOR PATIENTS WITH CANCER AND OTHER DISEASES OF HIGH UNMET NEED
